コーパス検索結果 (１語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 imize LVSWI can improve outcomes in the CICU setting.
2 those in the hospitalized nonintensive care setting.
3 onal replication is suggested for a clinical setting.
4 etabolism in a more physiologically relevant setting.
5 e been demonstrated only in the experimental setting.
6 transitions from the inpatient to outpatient setting.
7 as a circulating biomarker for this clinical setting.
8 ransfers this logic into a single-laboratory setting.
9 g variants and their relevance in a clinical setting.
10 d goal is to utilize the model in a clinical setting.
11 probes that can function within a biological setting.
12 f this metabolomics-based test in a clinical setting.
13 Cetuximab should not be used in this setting.
14 ctive to prevent infections in the home care setting.
15 HTLV-1 and its disease associations in this setting.
16 mirror image partners in a fully reciprocal setting.
17 owing abnormal FIT in an academic healthcare setting.
18 ification of 2, 3, 4A, or 4B in the clinical setting.
19 d attractive for translation to the clinical setting.
20 adherence and persistence in the real-world setting.
21 erfusion (IVLP) procedures within a hospital setting.
22 syndrome is under-recognized in the clinical setting.
23 The study took place in an institutional setting.
24 uces IL-1beta in the E. granulosus infection setting.
25 in a single clinical practice in an academic setting.
26 atter of debate, particularly in a pediatric setting.
27 of restraint use at the end of life in this setting.
28 coprescriptions of both medications in this setting.
29 of-Care tests (PoCT) to diagnose UTI in this setting.
30 ng from uncontrollable factors in a clinical setting.
31 is association in a prospective birth cohort setting.
32 vestigated whether eGFR only is safe in this setting.
33 associated with sleep disruption in the ICU setting.
34 olizumab plus chemotherapy in the first-line setting.
35 ve model was conducted in a forward-chaining setting.
36 implementing in a public health or research setting.
37 ients' experiences of care in acute hospital settings.
38 nd education in research and large-classroom settings.
39 tion in medical, research, and environmental settings.
40 en using a novel instrument for low-literacy settings.
41 mammalian cells in physiologically relevant settings.
42 roups shown in both experimental and natural settings.
43 catabolism in both preclinical and clinical settings.
44 cibility, and quality of VIA in humanitarian settings.
45 ne the etiological causes of ILI in clinical settings.
46 thrombosis and thrombo-inflammatory disease settings.
47 halation devices in high-risk, resource-poor settings.
48 evention measures, particularly in community settings.
49 er changes in community composition in these settings.
50 widely used in both academic and industrial settings.
51 d in the search for life in extraterrestrial settings.
52 tion in mice in prophylactic and therapeutic settings.
53 th and accurate nowcasts in multiple disease settings.
54 patients in the ICU and emergency department settings.
55 al studies' estimates were consistent across settings.
56 ildhood mortality particularly in low-income settings.
57 generative diseases in clinical and research settings.
58 ma in both therapeutic and adjuvant clinical settings.
59 f vertical HIV transmission cases in African settings.
60 tive power of different methods in different settings.
61 to the reasons for treatment failure in some settings.
62 es, which are rarely available in low-income settings.
63 both treatment-naive and acquired-resistance settings.
64 immune, inflammatory, and transplant disease settings.
65 tion could be cost-effective in all epidemic settings.
66 dividuals; four studies) across transmission settings.
67 uce the positive delta(34)S signature in arc settings.
68 f SARS-CoV-2 serologic tests in a variety of settings.
69 nsumption under lower nicotine concentration settings.
70 tion sample, it can be extended into patient settings.
71 effectiveness of GPseudoClust in a range of settings.
72 both preclinical drug screening and clinical settings.
73 ortance of REA in both clinical and research settings.
74 dy Universal PPE is protective in procedural settings.
75 ds, are available, even in protracted crisis settings.
76 and appropriate UVR exposure in experimental settings.
77 equired to confirm this finding in different settings.
78 s to curtailing harmful contagions in myriad settings.
79 ace as well as in educational and healthcare settings.
80 tiveness of rotavirus vaccines in a range of settings.
81 be performed at point-of-care (POC) and home settings.
82 le ASFV detection, intended for low resource settings.
83 eterogeneity frequently observed in clinical settings.
84 fections, both in the hospital and community settings.
85 linical characteristics of TB-DM vary across settings.
86 tological analyzers for resource-constrained settings.
87 nd/or variability in sexual practices across settings.
88 ated macrophage activation syndrome in those settings.
89 ial therapy must seek treatment in high-risk settings.
90 ignaling in cell-free, cellular, and in vivo settings.
91 cinations done in other types of health care settings.
92 ss transmission in many medical and clinical settings.
93 ally with potential future impact at the POC settings.
94 f acutely ill patients or in epidemiological settings.
95 s much higher in urban gardens than in rural settings.
96 ic health challenge in several resource poor settings.
97 ultrasensitive resistance testing in routine settings.
98 reatly limits their utility in physiological settings.
99 s in prehospital care, emergency, and remote settings.
100 based exemplar models dominant in laboratory settings.
101 are prevalent in both natural and industrial settings.
102 n and regression settings under various data settings.
103 egrated into HIV-care programs in low-income settings.
104 of patient mortality in nonobstetrical care settings, 15 found no evidence of an association with li
105 c strategy corrects the detection results by setting 6-(Ferrocenyl)hexanethiol (FcHT) as an internal
106 care and long-term care services in selected settings across the country; the effectiveness and susta
108 uncertain applicability to typical clinical settings, amyloid PET, (18)F-FDG PET, and MRI were highl
109 ries as seen in a military relevant clinical setting and a realistic approach for assessing potential
111 ified for three QTLs that enhance spike seed setting and grain size using gene expression data and we
112 l human T cell response to HPV in a clinical setting and offer groundbreaking insight into future dev
113 nal and newborn characteristics (health care setting and timeframe; maternal health factors; child's
114 epresentative of contrasting hydrogeomorphic settings and also capture change over a 25-years LULCC c
115 y TNFR1 assembly directly in native cellular settings and at physiological cell surface abundance.
116 of age) is very consistent across different settings and demonstrate how these data can provide robu
117 of covert plasmid propagation in healthcare settings and revealed the national distribution of the r
118 d psychosocial resources in cancer treatment settings and to ensure that psychological care receives
120 d culture is not widely available in endemic settings and, even when available, results can take up t
121 was validated in a busy real-world clinical setting, and clinicians were trained to effectively read
122 scaffolds, in both a continuum and discrete setting, and compare it with multivalent scaffolds with
150 experience discrimination in the health care setting, and they may not have access to medical profess
151 countries spanning low-income to high-income settings, and cost-effectiveness ratios were analysed at
154 1.4; 95% CI: 1.03-2.0), residing in an urban setting (aOR 1.8; 1.3-2.5), prior TB (aOR 4.6; 95% CI: 2
157 troviral treatment (ART) in resource limited settings are susceptible to high rates of acquired HIV d
158 with dilated cardiomyopathy in a multicenter setting as part of an emerging global consortium (MINICO
159 fibrosis in both preventive and therapeutic settings, as well as in the Dahl salt-sensitive rat mode
160 patient, emergency department, and inpatient settings at Vanderbilt Children's Hospital, Davidson Cou
161 ased WMS, to systematically handle parameter settings based on the principles of database management
162 ) models can be successfully applied in this setting because they are a powerful tool to analyze data
163 ected is simply infeasible for many taxa and settings because of the vast numbers of animals involved
164 882 persons tested positive in an ambulatory setting before subsequent hospitalization, a median of 4
165 sion injury (IRI), in heart attack or stroke settings, but also as an unavoidable consequence of soli
166 BAs (12HBAs) are altered in multiple disease settings, but the consequences of 12HBA abundance are in
167 mmended standard of care in resource-limited settings, but the mechanism of CPT's beneficial effects
168 to-pay threshold to a solid organ transplant setting by coining a new metric: the willingness-to-tran
172 h COVID-19, especially in the intensive care setting, despite a high utilization rate of thromboproph
173 cell culture systems and xenotransplantation settings diminishes CHD4 levels and derepresses the feta
174 care and relevant specialty care prevention settings, discuss the theory- and practice-based criteri
176 These resources are not available in POC settings, driving researchers to instead utilize isother
177 ardioCluster utilization in this preclinical setting establish fundamental insights, laying the frame
181 l resistance to antibiotics in this clinical setting further underlines the need for developing other
182 In therapeutic applications in the clinical setting, gene therapy offers several advantages over tra
184 Our results suggest that even in endemic settings, highly virulent clones can rapidly emerge dema
185 eet DR screening requirements in an outreach setting; however, not all devices are suitable in terms
186 not commonly observed in a non-critical care setting; however, they still have a negative impact on p
187 ndously plastic in both in vitro and in vivo settings; however, it remains unclear whether macrophage
188 independent from dose, kernel, and denoising settings; however, shows a dependency on patient size, b
189 n extracorporeal membrane oxygenation (ECMO) setting in rabbits, all without increasing the bleeding
193 y infer the comparative benefits or risks in settings, in which doing a randomised trial is not feasi
194 g ZipSeq, we mapped gene expression in three settings: in vitro wound healing, live lymph node sectio
199 ngs relate to categorization in more natural settings, involving complex, high-dimensional stimuli.
203 plication that frequently occurs in hospital settings, is often associated with hemodynamic compromis
204 Although it is generally safe in a clinical setting, it can be addictive, and several of its derivat
205 criteria can be applied in resource-limited settings, it may improve ICU outcomes associated with op
207 asting properties of PMNs in different tumor settings may in part reflect the effects of hypoxia on d
208 lity of DNA between the somatic and germline settings might be used to help identify disease-related
210 itals in the Pediatric Research in Inpatient Settings Network from December 1, 2018, through March 31
211 ral valve repair or replacement, and, in the setting of advanced heart failure, heart transplant and
214 mature myeloid cells that proliferate in the setting of cancer and have potent immunosuppressive func
216 unclear whether this remains the case in the setting of early initiation of combination antiretrovira
218 on of the option of adding olanzapine in the setting of hematopoietic stem cell transplantation.
220 n immunodeficiency virus (HIV) occurs in the setting of maternal and passively acquired antibodies, p
221 However, unlike T2D, GDM emerges in the setting of profound pregnancy-related physiologic change
222 6/1,000 patient-days) were all higher in the setting of prolonged acute mechanical ventilation than s
223 rate of misdiagnosed IE particularly in the setting of prosthetic valve endocarditis, paravalvular e
224 death in developed countries, occurs in the setting of reduced (HFrEF) or preserved (HFpEF) ejection
226 majority of the trials were performed in the setting of septic shock, and the most frequent comparato
230 e show in various Th1- and/or Th17-polarized settings of acute and chronic bacterial infection and of
232 on the influence of different algorithms and settings on feature extraction and following filtering s
233 ve approaches that use relaxed bwa parameter settings or filter bwa alignments can also reduce bias b
234 positive bacteria Micrococcus luteus In this setting, osa knockdown had a particularly strong effect
235 affected Adolescents in Resource Constrained Settings (PATC3H) research consortium, which investigate
237 sign and deployment in combinatorial library settings, providing a framework for the design of new DE
238 V-2 by BinaxNOW TM and RT-PCR in a community setting, rapid assay sensitivity was 100%/98.5%/89% usin
239 o limit proliferation in specific resistance settings, RB loss rendered cells completely independent
242 dus photography is usually used in screening settings, resulting in high false-positive and false-neg
243 e diet assessment and counseling in clinical settings, review existing tools, and discuss opportuniti
244 sly administered ibrutinib in the first-line setting significantly prolonged progression-free surviva
247 inflammatory processes in the heart failure setting, such as anti-inflammatory and immunomodulatory
248 cessing that can be used in other biological settings, such as being introduced into circuit designs
250 omic analyses demonstrate that in commercial settings sustainable microencapsulated diets facilitate
251 h altitude (4383 m; Cerro de Pasco, Peru), a setting that increases both pulmonary arterial pressure
252 synaptic cleft ([K(+) ](c) ) contributes to setting the hair cell and afferent membrane potentials;
253 hypothesized to be of general importance for setting the horizontal structure of the ocean mixed laye
257 stral 'L-shaped' humerus in the crown group, setting the stage for the diversification of terrestrial
259 icating these projects in other low-resource settings, thereby bringing genomic medicine in these cou
261 aptures this design concept in a homogeneous setting through the use of a redox non-innocent terpyrid
263 assessment and services in the preoperative setting to improve outcomes for this vulnerable populati
264 strategies are needed in all outpatient care settings to ensure accurate UTI diagnosis and reduce ina
265 f 8[7, 10] cmH(2)O above traditional ARDSnet settings to improve lung function, oxygenation and venti
266 tained or triggered more frequently in these settings to keep below available health capacity, with a
267 d, multiyear experiment in four agricultural settings to test if enhancing habitat adjacent to crops
271 RAS based on Doppler-ultrasound and clinical setting underwent IA-CTA with ultra-low iodine contrast
272 and emissive excitons are regenerated, thus setting up an equilibrium between excitons, charge-trans
273 lymers in the presence of "host" cells, thus setting up the possibility of making natural-synthetic h
276 e of AGO4, RdR1, RdR2, and DCL3 in a natural setting was revealed when plants individually silenced i
277 ion support tool for optimizing insulin pump settings was non-inferior to intensive insulin titration
278 arge, community-based integrated health care setting, we examined the risks of CRC and related death
279 greater exposure regardless of whether power settings were fixed or adjustable which is likely due to
280 rent level of TFA intake to a counterfactual setting where consumption was lowered to a theoretical m
281 transport principles for lineage tracing in settings where existing experimental strategies cannot b
284 o provide an improved level of protection in settings where P[6] rotavirus disease is endemic, irresp
285 d times would allow more effective triage in settings where patient management and infection control
286 t on public health are best addressed in the settings where such conditions are most prevalent (ie, j
288 y cells, like monocyte/macrophages, cellular settings where these epigenetic reader proteins couple p
289 tes, which are swift to derive in a clinical setting, will allow for the investigation of causality o
291 rer lung function in a non-western developed setting with less marked confounding by socioeconomic po
292 ostic decision making in specialist clinical settings with access to these biomarkers and might stimu
293 nd costs of different regimens of IPTp-DP in settings with different underlying sulfadoxine-pyrimetha
295 typhoid conjugate vaccines (TCV) be used in settings with high typhoid incidence; consequently, gove
297 cessful so far in the breast cancer clinical setting, with major unresolved challenges residing in ta
298 ity, would be consistent in a postcommercial setting, with relaxed eligibility criteria and bridging
300 edures in the US are performed in outpatient settings, yet little is known about facility-level varia